Refresh
Exchange Announcement • 02 May 2024 07:58
Exchange Announcement • 30 Apr 2024 07:41
Exchange Announcement • 29 Apr 2024 08:07
Exchange Announcement • 29 Apr 2024 08:06
Exchange Announcement • 29 Apr 2024 08:06
ENTITY
BeiGene (6160 HK)
BeiGene (6160 HK)
286
Analysis
Health Care • China
BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.
more
x